The primary function of the Administrative Core is to provide for the overall organizational, administrative and scientific management of the GI SPORE Program. This will be accomplished by the following aims: 1) Provide the organizational structure to efficiently enable all SPORE activities. 2) Provide the administrative foundation for the management of SPORE activities, including research projects, shared resources Cores, developmental research projects, career enhancement programs and supplemental actives. 3) Provide overall scientific management for the GI SPORE program. This Core will be responsible for managing the SPORE and disseminating information within the SPORE. The Core will also manage external interactions. The Core is designed for low-cost, yet efficient administration and communication in order to focus funds on research activities. Primary management of the SPORE is through the Steering Committee. The Steering Committee receives input from: 1) Research Project Teams 2) Committee of Research Project Leaders, 3) Core Investigators Committee 4) Developmental Research Projects Program 5) Career Development Committee. An institutional Advisory Board and External Advisory Board provide yearly formal evaluations of the SPORE program, including written reports to the Steering Committee. The communication component of the Core is directed at intra-SPORE, inter-SPORE and NCI research activities. The Core provides travel funds for Johns Hopkins GI SPORE participation in the NCI SPORE annual meetings, to include the SPORE Director/PI, members of the Committee of Research Project Leaders and other SPORE investigators. In addition, to impact on the incidence and mortality of colorectal and pancreatic cancer, communication of validated results to the medical community will occur via publication of the SPORE findings in medical journals, intra-institutional think-tanks and organized public conferences through the office of continuing medical education of the Johns Hopkins Medical Institution, news releases to the medical writers and press conferences for announcement of vital advances though the office of Public Affairs of the Johns Hopkins Medical Institution, and when appropriate alerts are coordinated through NCI program staff.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA062924-26
Application #
10006158
Study Section
Special Emphasis Panel (ZCA1)
Project Start
1997-02-28
Project End
2023-08-31
Budget Start
2020-09-01
Budget End
2021-08-31
Support Year
26
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21205
Adler, B L; Pezhouh, M K; Kim, A et al. (2018) Histopathological and immunophenotypic features of ipilimumab-associated colitis compared to ulcerative colitis. J Intern Med 283:568-577
Ma, Qianqian; Gabelli, Sandra B; Raben, Daniel M (2018) Diacylglycerol kinases: Relationship to other lipid kinases. Adv Biol Regul :
Robinson, Cemre; Estrada, Andrea; Zaheer, Atif et al. (2018) Clinical and Radiographic Gastrointestinal Abnormalities in McCune-Albright Syndrome. J Clin Endocrinol Metab 103:4293-4303
Klein, Alison P; Wolpin, Brian M; Risch, Harvey A et al. (2018) Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. Nat Commun 9:556
Kuboki, Yuko; Fischer, Catherine G; Beleva Guthrie, Violeta et al. (2018) Single-cell sequencing defines genetic heterogeneity in pancreatic cancer precursor lesions. J Pathol :
Zhang, Jiajia; Quadri, Shafat; Wolfgang, Christopher L et al. (2018) New Development of Biomarkers for Gastrointestinal Cancers: From Neoplastic Cells to Tumor Microenvironment. Biomedicines 6:
Hata, Tatsuo; Suenaga, Masaya; Marchionni, Luigi et al. (2018) Genome-Wide Somatic Copy Number Alterations and Mutations in High-Grade Pancreatic Intraepithelial Neoplasia. Am J Pathol 188:1723-1733
Noë, Michaël; Rezaee, Neda; Asrani, Kaushal et al. (2018) Immunolabeling of Cleared Human Pancreata Provides Insights into Three-Dimensional Pancreatic Anatomy and Pathology. Am J Pathol 188:1530-1535
Schunke, Kathryn J; Rosati, Lauren M; Zahurak, Marianna et al. (2018) Long-term analysis of 2 prospective studies that incorporate mitomycin C into an adjuvant chemoradiation regimen for pancreatic and periampullary cancers. Adv Radiat Oncol 3:42-51
Zhang, Jiajia; Wolfgang, Christopher L; Zheng, Lei (2018) Precision Immuno-Oncology: Prospects of Individualized Immunotherapy for Pancreatic Cancer. Cancers (Basel) 10:

Showing the most recent 10 out of 883 publications